News
Important Only
Aeries Technology Swings to Q1 Profit
Key Points- Net income (GAAP) was $1.7 million for Q1 FY2026, up $17.0 million year-over-year, with operating profit also restored.- as the business exited non-core operations to focus entirely on AI-powered Global Capability Center services.- Management reaffirmed full-year FY2026 guidance of $74–8...The Motley Fool
Thu, Aug 14
AFC Gamma Posts Q2 Loss and 73% EPS Drop
Key PointsDistributable earnings per share (non-GAAP) fell short of expectations at $0.15Net income (GAAP) swung to a loss of $13.2 million, reflecting heightened credit loss provisions and issues among cannabis borrowers.The company announced plans to convert from a mortgage REIT to a BDC, signalin...The Motley Fool
Thu, Aug 14
Lm Funding America Posts Q2 Profit Swing
Key PointsEPS (GAAP) turned positive at $0.02 in Q2 2025, sharply higher than analyst expectations of a $0.52 loss, mainly due to a $3.8 million Bitcoin revaluation gain.Missing the estimated $2.0 million (GAAP) revenue and down 36.0% year-over-year from Q2 2024.Mining margin rose to 41.0% in Q2 202...The Motley Fool
Thu, Aug 14
Prelude Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Prelude Therapeutics Inc PRLD.OQ reported a quarterly adjusted loss of 41 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -46 cents. The mean expectation of four analysts for the quarter was for a loss of 44 cents per share. ...Reuters
Thu, Aug 14
Qxo Posts 1,906 Million Revenue in Q2
Key PointsNon-GAAP earnings per share came in at $0.11, nearly triple the analyst estimate of $0.04.Revenue (GAAP) surged to $1,906.4 million, driven by the Beacon Roofing Supply acquisition and topping GAAP estimates by $32.7 million.Adjusted EBITDA, a non-GAAP financial measure, reached $204.6 mil...The Motley Fool
Thu, Aug 14
3 Reasons XRP Is Surging Right Now
Key PointsXRP is having a strong summer.Technology and new public policy are now aligning for its success.It'll likely have a strong fall season and beyond. 10 stocks we like better than XRP › When investors think they can finally see the market's road ahead, they tend to step on the gas. That's wha...The Motley Fool
Thu, Aug 14
SpartanNash Posts 46% Profit Drop in Q2
Key PointsNet earnings (GAAP) fell 46.1% as retail profitability softened and acquisition-related costs mounted.No fiscal 2025 guidance provided due to the pending C&S acquisition; cost-saving targets and integration efforts remain in focus.These 10 stocks could mint the next wave of millionaires › ...The Motley Fool
Thu, Aug 14
Cellectar Cuts Q2 Losses and Expenses
Key PointsNet loss per share (GAAP) was $(3.39) for Q2 2025, beating analyst estimates of $(3.72) (GAAP) and improving from a GAAP diluted net loss per share of $(5.43) in Q2 2024.Research and development expenses dropped 67.1% compared to Q2 2024. This decrease was primarily driven by lower clinica...The Motley Fool
Thu, Aug 14
Larimar Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Larimar Therapeutics Inc LRMR.OQ reported a quarterly adjusted loss of 41 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -34 cents. The mean expectation of twelve analysts for the quarter was for a loss of 48 cents per share....Reuters
Thu, Aug 14
reAlpha Tech Sales Jump 1,909 Percent
Key PointsRevenue was $1.25 million and exceeded the analyst estimate of $1.20 million (GAAP).Net loss (GAAP) was $4.1 million, with earnings per share (GAAP) of $(0.08).Gross margin (GAAP) fell from 71% to 50% compared to Q2 2024.These 10 stocks could mint the next wave of millionaires › reAlpha Te...The Motley Fool
Thu, Aug 14
TerraVest Industries Inc reports results for the quarter ended June 30 - Earnings Summary
TerraVest Industries Inc TVK.TO reported quarterly adjusted earnings of 53 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 61 cents. The mean expectation of five analysts for the quarter was for earnings of 99 cents per share....Reuters
Thu, Aug 14
Abeona Posts Q2 Profit on Asset Sale
Key PointsHeadline profit and GAAP EPS of $1.71 for Q2 2025 resulted almost entirely from a one-time asset sale rather than ongoing business operations.Q2 2025 marked the first revenue recognition ($0.4 million, GAAP), though there were no therapeutic product sales; ZEVASKYN launch only begins in th...The Motley Fool
Thu, Aug 14
Is This a Sign Opendoor Technologies Is on the Right Track?
Key PointsOpendoor generated modest sales growth last quarter while also shrinking its losses.However, gross margins for the residential real estate company remain incredibly thin.10 stocks we like better than Opendoor Technologies › Opendoor Technologies (NASDAQ: OPEN) has been one of the hottest m...The Motley Fool
Thu, Aug 14
FitLife Brands Reports 5 Percent Q2 Drop
Key PointsGAAP revenue and diluted earnings per share both narrowly exceeded consensus estimates for Q2 2025.Consolidated GAAP results declined year-over-year, with revenue down 5% compared to Q2 2024 and gross margin slipping to 42.8%.The Irwin Naturals acquisition was completed after quarter-end, ...The Motley Fool
Thu, Aug 14
Palvella Posts Cash Gain and Trial Wins
Key PointsClinical progress accelerated as Phase 3 SELVA enrollment outpaced targets and pipeline expansion plans were outlined for later in 2025.Cash balance stood at $70.4 million as of June 30, 2025, funding operations into the second half of 2027, while operating expenses rose sharply compared t...The Motley Fool
Thu, Aug 14
LATAM Airlines shares drop after $767 mln secondary offering priced
** U.S.-listed shares of Chile-based LATAM Airlines LTM.N down 4.5% premarket to $42.74 after secondary offering priced ** LTM announces 18 mln American Depositary Shares (ADS) sold by existing shareholders at $42.60, which equates to $766.8 mln gross proceeds ** Offering size bo...Reuters
Thu, Aug 14
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Evoke Pharma Inc EVOK.OQ reported a quarterly adjusted loss of 62 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -93 cents. The lone analyst forecast for the quarter was for a loss of 30 cents per share. Revenue rose 47.1% t...Reuters
Thu, Aug 14
U.S. STOCKS ON THE MOVE-Bullish, Tapestry, Birkenstock
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures were muted on Thursday following a strong run on Wall Street this week and investors awaited fresh economic data to gauge the Federal Reserve's monetary policy v...Reuters
Thu, Aug 14
Golar LNG gains on plans to order its fourth FLNG unit
** Shares of Golar LNG GLNG.O rise 3.5% to $41.61 premarket** Company says based on the increasing demand for floating liquefied natural gas (FLNG), it plans to order its fourth FLNG unit before locking in a charter to drive competitive tension** GLNG says it is the same approach successfully execut...Reuters
Thu, Aug 14
Ibotta Q2 Revenue Falls Short
Ibotta(NYSE:IBTA) reported second quarter 2025 earnings on August 13, 2025, with revenue of $86 million, a 2% year-over-year decline, and adjusted EBITDA of $17.9 million. Management cited a 48% shortfall at the midpoint of prior guidance and issued third quarter guidance below expectations due to o...The Motley Fool
Thu, Aug 14
